Empire Life Investments’s Legend Biotech LEGN Stock Holding History

Empire Life Investments’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.57M	Sell	296,586 -4,372	-1%	-$118K	0.48%	57
2026 Q1	$5.73M	Sell	300,958 -21,978	-7%	-$419K	0.35%	62
2025 Q4	$7.02M	Sell	322,936 -2,072	-0.6%	-$59.4K	0.4%	61
2025 Q3	$10.6M	Buy	325,008 +47,081	+17%	+$1.74M	0.62%	53
2025 Q2	$9.86M	Buy	277,927 +112,266	+68%	+$3.64M	0.63%	54
2025 Q1	$5.62M	Buy	165,661 +28,930	+21%	+$1.04M	0.37%	67
2024 Q4	$4.45M	Buy	136,731 +38,043	+39%	+$1.58M	0.28%	69
2024 Q3	$4.81M	Buy	98,688 +42,368	+75%	+$2.26M	0.29%	67
2024 Q2	$2.49M	Buy	+56,320	New	+$2.6M	0.16%	71

Other funds holding LEGN

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

EFMH

E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TPSF

Texas Permanent School Fund Austin, Texas $2.26B AUM 7.02% 1-Year Est. Return

Empire Life Investments's LEGN Position: Q2 2026 in Review

Empire Life Investments reduced its Legend Biotech (LEGN) stake by 1.5% in Q2 2026, selling an estimated $118K and leaving 296,586 shares worth $8.57M. The position accounts for 0.48% of the portfolio, ranked #57.

Empire Life Investments first reported a position in LEGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $10.6M in Q3 2025. 42 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Empire Life Investments held 296,586 shares of Legend Biotech worth $8.57M as of Q2 2026.
Empire Life Investments sold 4,372 Legend Biotech shares in Q2 2026, an estimated $118K.
Legend Biotech made up 0.48% of Empire Life Investments's portfolio in Q2 2026, its #57 holding.
Empire Life Investments first reported a position in Legend Biotech in Q2 2024 and has held it in 9 quarters since.
Empire Life Investments's Legend Biotech position peaked at $10.6M in Q3 2025.
42 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Empire Life Investments's 13F filing for Q2 2026, filed 24 Jul 2026.